Galectin Therapeutics Inc. (NASDAQ:GALT – Get Rating) – Investment analysts at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Galectin Therapeutics in a research note issued on Wednesday, May 17th. HC Wainwright analyst E. Arce now expects that the company will post earnings of $1.45 per share for the year, down from […]
Galectin Therapeutics Inc. (NASDAQ:GALT – Get Rating) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.53 and traded as high as $1.85. Galectin Therapeutics shares last traded at $1.77, with a volume of 31,522 shares. Wall Street Analyst Weigh In GALT has been the […]
StockNews.com started coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a research note released on Wednesday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and issued a $11.00 price objective on shares of Galectin Therapeutics in a research note on Friday, March 3rd. […]
Analysts at StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Get Rating) in a report released on Wednesday. The firm set a “hold” rating on the stock. Separately, HC Wainwright reissued a “buy” rating and issued a $11.00 price target on shares of Galectin Therapeutics in a research report on Friday, March 3rd. […]